Skip to main content
SpringerLink
Log in

Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell line

  • Published:
Pflügers Archiv Aims and scope Submit manuscript

Abstract

Myasthenia gravis (MG) is an autoimmune disorder in which anti-acetylcholine receptor (AChR) antibodies cause muscle weakness. In 10–15% of MG patients anti-AChR antibodies are undetectable (seronegative MG, SMG), though clinical and experimental evidence points to causative circulating factors. Using whole-cell patch-clamp techniques, we investigated the effects of heat-inactivated plasma from SMG patients (n=7) on voltage-gated sodium [I Na(V)] and ACh-induced nicotinic AChR (nAChR) currents in the human rhabdomyosarcoma cell line TE671/RD, comparing the results to those obtained with plasma from healthy individuals (HC, n=6), patients with Guillain-Barré syndrome (GBS, n=3) or those with other neurological diseases (OND, n=3). None of the plasma samples inhibited I Na(V). nAChR currents were rapidly (<1 min) and significantly (P<0.01) reduced by a 1∶10 dilution of plasma from SMG patients compared with plasma from healthy controls and were not restored by washing. The inhibition appeared in some cases to be calcium dependent since for one of three plasmas it was prevented by 10 mM EGTA in the patch pipette. Currents were also reduced by two of three plasmas obtained from GBS patients at 1∶3 dilution, but not by the three plasmas from patients with ONDs. The rapid action of plasma from SMG patients argues against an antibodyinduced reduction in nAChR numbers; its calcium dependence in one case suggests action by a second messenger that might involve nAChR phosphorylation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barrett-Jolley RA, Byrne NG, Vincent A, Newsom-Davis J (1991) Effects of seronegative myasthenic plasma on the voltage gated sodium channel and the ACh activated cation channel of a whole-cell voltage clamped muscle cell line. J Autoimmun 4:2

    Google Scholar 

  2. Barrett-Jolley RA, Byrne NG, Vincent A, Newsom-Davis J (1992) Inhibition of ACh-currents by human plasma in a whole-cell voltage clamped human muscle cell line. J Physiol (Lond) 446:267P

    Google Scholar 

  3. Barrett-Jolley RA, Byrne NG, Newsom-Davis J, Vincent A (1992) Caffeine inhibition of ACh nicotinic currents in the human muscle (TE671) cell line not mediated by cyclic AMP/ Ca2+. J Physiol (Lond) 452:193P

    Google Scholar 

  4. Brinkmeir H, Wollinksy KH, Hülser P-J, Seewald MJ, Mehrkens H-H, Kornhuber HH, Rüdel R (1992) The acute paralysis in Guillain-Barré syndrome is related to a Na+ channel blocking factor in the cerebrospinal fluid. Pflügers Arch 421:552–557

    Google Scholar 

  5. Cockcroft S, Thomas GMH (1992) Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. Biochem J 288:1–14

    Google Scholar 

  6. Falker B, Ruppersberg JP, Spittelmeister W, Rüdel R (1990) Inactivation of human sodium channels and the effect of tocainide. Pflügers Arch 415:693–700

    Google Scholar 

  7. Gambale F, Montal M (1990) Voltage-gated sodium channels expressed in the human cerebellar medulloblastoma cell line TE671. Mol Brain Res 7:123–129

    Google Scholar 

  8. Grassi F, Monaco L, Eusebi F (1987) Acetylcholine receptor channel properties in rat myotubes exposed to forskolin. Biochem Biophys Res Commun 147:1000–1007

    Google Scholar 

  9. Grassi F, Giovannelli A, Fucile S, Mattei E, Eusebi F (1993) Cholinergic responses in cloned human TE671/RD tumour cells. Pflügers Arch 425:117–125

    Google Scholar 

  10. Giovannelli A, Farini D, Gauzzi MC, Alema S, Eusebi F (1990) Regulation of acetylcholine receptor desensitisation in mouse myotubes by cytosolic cyclic AMP. Cell Signal 2:347–352

    Google Scholar 

  11. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp technique for high-resolution current recordings from cells and cell-free membrane patches. Pflügers Arch 391:85–100

    Google Scholar 

  12. Huganir RL, Greengard P (1987) Regulation of receptor function by protein phosphorylation. Trends Pharmacol Sci 8:472–475

    Google Scholar 

  13. Huganir RL, Delcour AH, Greengard P, Hess GP (1986) Phosphorylation of the nicotinic acetylcholine receptor regulates its rate of desensitisation. Nature 321:774–776

    Google Scholar 

  14. Lang B, Richardson G, Rees J, Vincent A, Newsom-Davis J (1988) Plasma from myasthenia gravis patients reduces acetylcholine receptor agonist-induced Na+ flux into TE671. J Neuroimmunol 19:141–148

    Google Scholar 

  15. Laurenza A, McHugh-Sutkowski E, Seamon KB (1989) Forskolin: a specific stimulator of adenyl cyclase of a diterpene with multiple sites of action. Trends Pharmacol Sci 10:442–447

    Google Scholar 

  16. Luther MA, Schoepfer T, Whiting P, Casey B, Blatt Y, Montal MS, Montal M, Lindstrom J (1989) A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671. J Neurosci 9:1082–1096

    Google Scholar 

  17. Middleton P, Fernán J, Schuetze SM (1986) Forskolin increases the rate of ACh-receptor desensitization at rat soleus endplates. Proc Natl Acad Sci USA 83:4967–4971

    Google Scholar 

  18. Mier AK, Havard CWH (1985) Diaphragmatic myasthenia in mother and child. Postgrad Med J 61:725–727

    Google Scholar 

  19. Mossman S, Vincent A, Newsom-Davis J (1986) Myasthenia gravis without acetylcholine receptor antibody: a distinct disease entitiy. Lancet i:116–119

    Google Scholar 

  20. Mulle C, Benoit P, Pinset C, Roa M, Changeux J-P (1988) Calcitonin gene-related peptide enhances the rate of desensitization of the nicotinic acetylcholine receptor in cultured mouse muscle cells. Proc Natl Acad Sci USA 85:5728–5732

    Google Scholar 

  21. Nishizuka Y (1988) The molecular heterogenity of protein kinase C and implications for cellular regulation. Nature 334:661–665

    Google Scholar 

  22. Pappone PA (1980) Voltage clamp experiments in normal and denervated mammalian skeletal muscle fibres. J Physiol (Lond) 306:377–410

    Google Scholar 

  23. Revah F, Mulle C, Pinset C, Audhya T, Goldstein G, Changeux J-P (1987) Calcium-dependent effect of the thymic polypeptide thymopoietin on the desensitization of the nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 84:3477–3481

    Google Scholar 

  24. Siara J, Ruppersberg JP, Rüdel R (1990) Human nicotinic acetylcholine receptor: the influence of second messengers, on activation and desensitization. Pflügers Arch 415:701–706

    Google Scholar 

  25. Stratton MR, Darling J, Pilkington GJ, Lantos PL, Reeves BR, Cooper CS (1989) Characterization of the human cell line TE671. Carcinogenesis 10:899–905

    Google Scholar 

  26. Vincent A, Newsom-Davis J (1985) Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 47:1246–1252

    Google Scholar 

  27. Vincent A, Li Z, Hart A et al. (1993) Seronegative myasthenia gravis. Evidence for plasma factor(s) interfering with acetylcholine receptor function. Ann NY Acad Sci 681:529–538

    Google Scholar 

  28. Wagoner PK, Pallotta BS (1988) Modulation of ACh-receptor desensitisation by forskolin is independent of cAMP. Science 240:1655–1657

    Google Scholar 

  29. Willcox N, Vincent A (1988) Myasthenia gravis as an example of organ-specific autoimmune disease. In: Bird AG, Calvert JE (eds) The B lymphocyte in human disease. Oxford University Press, London, pp 496–506

    Google Scholar 

  30. Yamamoto T, Vincent A, Ciulla T, Lang B, Johnston I, Newsom-Davis J (1991) Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM. Ann Neurol 30:550–557

    Google Scholar 

Download references

Author information

Author notes

  1. Richard Barrett-Jolley

    Present address: Department of Physiology, University of Leicester, Leicester, UK

  2. Nick Byrne

    Present address: Department of Applied Biological Sciences, Coventry University, Coventry, UK

Authors and Affiliations

  1. Neurosciences Group, Institute of Molecular Medicine, John Radcliffe Hospital, OX3 9DU, Oxford, UK

    Richard Barrett-Jolley, Nick Byrne, Angela Vincent & John Newsom-Davis

Authors
  1. Richard Barrett-Jolley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nick Byrne
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angela Vincent
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John Newsom-Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barrett-Jolley, R., Byrne, N., Vincent, A. et al. Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell line. Pflugers Arch. 428, 492–498 (1994). https://doi.org/10.1007/BF00374570

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00374570

Key words

Search

Navigation